Features

Filter by:
All Sectors
All Companies
Clear all filters
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Snowline Gold
Metals & Mining
January 17, 2023

Snowline Gold: Exploring District-Scale Gold Systems in the Selwyn Basin

With a seventeen-project portfolio and their flagship projects covering ~72,000 hectares in the prospective yet underexplored Selwyn Basin, Snowline tells BTV about being a first mover in the region.

Metals & Mining
institutional traders
retail investor
qualified institutional buyers
institutional investors
individual investors
AuTECO Minerals: 2.2Moz of Gold at 7.8g/t and Growing Rapidly
Metals & Mining
January 17, 2023

AuTECO Minerals: Growing Rapidly with a High-Grade 2.2M Ounce Resource

AuTECO Minerals is located in Ontario and they're working on the Pickle Crow project.

Metals & Mining
No items found.
Metals & Mining
January 3, 2023

York Harbour: An Overlooked Property Leads to Potential for a Big Discovery

York Harbour Metals Inc is an exploration and development company focused on the York Harbour Copper-Zinc Project, a past producing mine located approximately 27 km from Corner Brook, Newfoundland. It also has an interest in Phoenix Gold Properties.

Metals & Mining
stock market
stock market news
Investing
Banyan Gold
Metals & Mining
January 3, 2023

Banyan Gold: A 4-Million Ounce Mineral Resource Estimate

Banyan Gold is located in the Yukon and they're in the heart of the new Yukon gold rush. They have a 4 million oz resource with an expansion potential to Tier 1 status.

Metals & Mining
stock market
stock market news
Investing
Defence Therapeutics: Developing Next Generation Therapies to Combat Cancer with Propietary ACCUM™ Technology
January 2, 2023

Defence Therapeutics: Developing Next Generation Therapies to Combat Cancer with Propietary ACCUM™ Technology

Cancer treatment along with other infectious diseases need clinical solutions and this company may have one. BTV interviews Defense Therapeutics to learn about their proprietary ACCUM™ technology and its proven ability to deliver treatment drugs to diseased cells.

institutional traders
institutional traders
retail investors
qualified institutional buyers
institutional investors
No items found.